Ascent Group’s Medline Inc MDLN Stock Holding History

Ascent Group’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,420	Closed	-$731K	–	846
2026 Q1	$731K	Buy	+16,420	New	+$725K	0.03%	429

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ascent Group's MDLN Position: Q2 2026 in Review

Ascent Group sold out of Medline Inc (MDLN) in Q2 2026, closing a stake of 16,420 shares — an estimated $731K sold.

Ascent Group first reported a position in MDLN in Q1 2026 and held it in 1 quarter. The position peaked at $731K in Q1 2026. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Ascent Group reported no remaining Medline Inc position as of Q2 2026 after selling out during the quarter.
Ascent Group sold 16,420 Medline Inc shares in Q2 2026, an estimated $731K.
Ascent Group first reported a position in Medline Inc in Q1 2026 and held it in 1 quarter.
Ascent Group's Medline Inc position peaked at $731K in Q1 2026.
407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.